Global Medical Fentanyl Market 2023-2030

    In Stock

    Coming Soon




     As comparison to morphine, fentanyl is a potent synthetic opioid analgesic that is 50–100 times more potent. Fentanyl is manufactured illegally but is also prescribed for pain in its prescription form. The most frequently used medicines in overdose deaths are fentanyl and other synthetic opioids.


    The following are the different ways that illegal fentanyl is offered for sale: as a powder, as little candies dropped on blotter paper, in eye droppers or nasal sprays, or as tablets shaped to resemble actual prescription opioids.


    Cocaine, heroin, methamphetamine, and MDMA are among the substances that are combined with illegal fentanyl in this practise. Because many people are not aware that fentanyl has been added, this is very risky.


    Fentanyl functions by attaching to opioid receptors in the body, which are located in parts of the brain that regulate pain and emotions. Extreme joy, sleepiness, nausea, confusion, constipation, sedation, tolerance, addiction, respiratory depression and arrest, unconsciousness, coma, and death are only a few of its side effects.


    The risk of overdosing is significantly increased by fentanyl’s extreme strength, particularly if a drug user is ignorant that a powder or tablet contains it. They might take less opioids than they should, which could lead to overdosing. To reverse a fentanyl overdose, a person may be administered the drug naloxone.


    The strength of fentanyl may require many doses of naloxone. Those who are addicted to fentanyl and other opioids can be effectively treated with medication combined with behavioural treatments.




    infographic: Medical Fentanyl Market , Medical Fentanyl Market Size, Medical Fentanyl Market Trends, Medical Fentanyl Market Forecast, Medical Fentanyl Market Risks, Medical Fentanyl Market Report, Medical Fentanyl Market Share


    The Global Medical Fentanyl Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    The REMS fentanyl was launched by Actiq,  in part to make sure that only patients who are tolerant to opioids are prescribed and given TIRF medications.A prescription opioid pain reliever called fentanyl is present in transmucosal immediate-release fentanyl medications.


    Those with cancer who regularly take other opioid painkillers round-the-clock for pain are given TIRF medications to treat breakthrough pain.


    Fentora fentanyl citrate buccal tablet and its generic equivalents, Lazanda fentanyl nasal spray, Onsolis fentanyl buccal soluble film, Subsys fentanyl sublingual spray, and fentanyl citrate sublingual tablets are among the TIRF medications. For certain products, the FDA has mandated a Risk Evaluation and Mitigation Strategy.



    • Actiq, 
    • Fentora,
    •  Abstral, 
    •  Duragesic
    • Subsys,
    •  Lazanda,



    1. How many Medical Fentanyl are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Medical Fentanyl and key vendor selection criteria
    3. Where is the Medical Fentanyl manufactured? What is the average margin per unit?
    4. Market share of Global Medical Fentanyl market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Medical Fentanyl in-house
    6. key predictions for next 5 years in Global Medical Fentanyl market
    7. Average B-2-B Medical Fentanyl market price in all segments
    8. Latest trends in Medical Fentanyl market, by every market segment
    9. The market size (both volume and value) of the Medical Fentanyl market in 2023-2030 and every year in between?
    10. Production breakup of Medical Fentanyl market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop